Analyst Ratings for Cidara Therapeutics (CDTX)
CDTX Rating Summary
CDTX Price Target Summary
- Highest: $9.00 (Aegis Capital)
- Lowest: $4.00 (Wedbush)
- Average: $6.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.50 (+280.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$6.50 (+280.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/4/2021 | Aegis Capital | Nathan Weinstein | New Coverage | Buy (N/A) |
9.00 (N/A) |
2.23 (1.71) |
-23.32% | Details |
| 3/10/2020 | Maxim Group | Jason McCarthy | New Coverage | Buy (N/A) |
10.00 (N/A) |
2.65 (1.71) |
-35.47% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
